Dr. Michelle Olsheski

Radiation OncologyFemale15+ years of experience
Dr. Michelle Olsheski is a radiation oncologist in Springfield, Massachusetts. She graduated from Temple University School of Medicine in 2007 and has been in practice for 15+ years.
LocationEducationRatingsAbout MeHospitalsConditions TreatedSpecialtySimilar

Location

Dr. Michelle Olsheski
271 Carew St
Springfield, Massachusetts 01104

Education

Medical school

Dr. Olsheski attended Temple University School of Medicine and graduated in 2007 (15 years ago). Temple University School of Medicine is ranked #68 number in the "Best Medical Schools" by U.S. News.

About Me

Dr. Olsheski works at Springfield Radiation Oncology Associates, PC, which has 2 other health providers.

Primary specialty
Radiation Oncology
Years of experience
15+ years
Gender
Female
NPI
1437313558

Hospital Affiliations

Dr. Olsheski is affiliated with the following hospitals.

Mercy Medical CTR

Conditions Treated

As a radiation oncology, Dr. Olsheski may see patients with the following conditions. Please check with Dr. Olsheski what conditions she treats. Dr. Olsheski may treat additional conditions not listed.

  • Acoustic neuroma
  • Acute lymphocytic leukemia
  • Adnexal tumors
  • Adrenal cancer
  • Ameloblastoma
  • Ampullary cancer
  • Anal cancer
  • Bladder cancer
  • Bone cancer
  • Brain cancer
Show more +

Specialties

Dr. Olsheski is a radiation oncologist.

Radiation Oncology

A radiation oncologist is a specialist physician who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. A radiation oncologist may also use radiation to treat some benign diseases, including benign tumors.